Neurovance secures $6.3 million in Series A-1 financing - MarketLine Financial Deals

Neurovance secures $6.3 million in Series A-1 financing

Neurovance secures $6.3 million in Series A-1 financing - MarketLine Financial Deals
Neurovance secures $6.3 million in Series A-1 financing
Published Apr 03, 2014
4 pages — Published Apr 03, 2014
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Neurovance, Inc., a US-based clinical stage neuroscience-focused company, has secured $6.3 million in Series A1 financing

  
Source:
Document ID
MA145774_140408
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Neurovance secures $6.3 million in Series A-1 financing" Apr 03, 2014. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Neurovance-secures-6-3-million-in-Series-A-1-financing-2052-101508>
  
APA:
MarketLine Financial Deals. (2014). Neurovance secures $6.3 million in Series A-1 financing Apr 03, 2014. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Neurovance-secures-6-3-million-in-Series-A-1-financing-2052-101508>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.